ÂÜÀòÂÒÂ×

Marla Bornstein is Vice President, Business Development for Neomorph. She brings over 20 years of biotech experience in business development, corporate strategy, new product planning, marketing, and regulatory affairs. Most recently, Marla was Senior Director, Business Development at Illumina where she led pharmaceutical companion diagnostic partnerships and established an IVD partnering program for Illumina’s sequencing platforms. At Biogen Idec, Marla played an integral role in portfolio prioritization initiatives and was instrumental in driving oncology new product marketing launch plans. Prior to Biogen Idec, Marla worked as a strategy consultant for Analytica International, performing market assessments and building global pricing and reimbursement strategies for life science companies. Marla began her career in regulatory affairs at Pharmascience. Marla has a BSc in Microbiology and Immunology from McGill University and an MBA from Columbia University.